Parkinson's Disease Trial, Recruiting NCT06950255 Sponsor: Federal University of Minas Gerais Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06950255
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's that does not have a known cause) by a neurologist
  • People whose Parkinson's disease falls between stages II and IV on a standard scale used to measure how advanced the condition is (the modified Hoehn & Yahr Scale)
  • People who have been on a stable Parkinson's medication plan for at least 6 months, with no recent changes
  • People who are able to walk independently along a 14-metre corridor at a slower walking pace (no faster than 1.1 metres per second)
  • People who are able to safely and correctly use a single-point walking cane, and who have not regularly used any walking aid or assistive device since their Parkinson's diagnosis

Who may not be able to join:

  • People who have cognitive impairment (problems with memory or thinking), as measured by a standard test called the Mini Mental State Examination
  • People who use deep brain stimulation (a device surgically implanted to help control Parkinson's symptoms)
  • People who have another neurological condition (affecting the brain or nerves), heart or lung condition, or a muscle or bone condition that could affect their ability to safely take part in the trial's tests

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christina DCM Faria, Doctor, Federal University of Minas Gerais

Phone: +55 (31) 34097448

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Federal University of Minas Gerais
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change from baseline in gait speed

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov